- Stocks
- Healthcare
- NYSE: TMO

Price (delayed)

$593.37

Market cap

$233.82B

P/E Ratio

27.33

Dividend/share

$1.04

EPS

$21.71

Enterprise value

$243.5B

Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry .

TMO's EPS has soared by 77% year-on-year

Thermo Fisher Scientific's net income has soared by 76% YoY

The stock's price to earnings (P/E) is 14% less than its 5-year quarterly average of 31.7 but 8% more than its last 4 quarters average of 25.4

The debt has increased by 16% QoQ and by 2.9% YoY

What are the main financial stats of TMO

Market
Valuations
Earnings

Shares outstanding

394.05M

Market cap

$233.82B

Enterprise value

$243.5B

Price to earnings (P/E)

27.33

Price to book (P/B)

6.03

Price to sales (P/S)

5.99

EV/EBIT

23.44

EV/EBITDA

18.88

EV/Sales

6.23

Revenue

$39.06B

EBIT

$10.39B

EBITDA

$12.9B

Free cash flow

$7.93B

Per share
Balance sheet
Liquidity

EPS

$21.71

Free cash flow per share

$20.12

Book value per share

$98.39

Revenue per share

$99.13

TBVPS

$88.23

Total assets

$73.6B

Total liabilities

$34.89B

Debt

$21.71B

Equity

$38.71B

Working capital

$16.97B

Debt to equity

0.56

Current ratio

3.19

Quick ratio

2.27

Net debt/EBITDA

0.75

Margins
Efficiency
Dividend

EBITDA margin

33%

Gross margin

51.1%

Net margin

21.9%

Operating margin

27%

Return on assets

12.4%

Return on equity

23.6%

Return on invested capital

31.1%

Return on capital employed

15.8%

Return on sales

26.6%

Dividend yield

0.18%

DPS

$1.04

Payout ratio

4.8%

How has the Thermo Fisher Scientific stock price performed over time

Intraday

0.55%

1 week

-5.09%

1 month

-8.86%

1 year

16.95%

YTD

-11.07%

QTD

-11.07%

How have Thermo Fisher Scientific's revenue and profit performed over time

Revenue

$39.06B

Gross profit

$19.94B

Operating income

$10.56B

Net income

$8.57B

Gross margin

51.1%

Net margin

21.9%

The operating income has soared by 77% YoY

Thermo Fisher Scientific's net income has soared by 76% YoY

Thermo Fisher Scientific's gross profit has increased by 48% YoY

Thermo Fisher Scientific's revenue has increased by 37% YoY and by 2.1% from the previous quarter

What is Thermo Fisher Scientific's growth rate over time

What is Thermo Fisher Scientific stock price valuation

P/E

27.33

P/B

6.03

P/S

5.99

EV/EBIT

23.44

EV/EBITDA

18.88

EV/Sales

6.23

TMO's EPS has soared by 77% year-on-year

The stock's price to earnings (P/E) is 14% less than its 5-year quarterly average of 31.7 but 8% more than its last 4 quarters average of 25.4

The P/B is 51% above the 5-year quarterly average of 4.0 and 12% above the last 4 quarters average of 5.4

The company's equity rose by 22% YoY and by 5% QoQ

Thermo Fisher Scientific's revenue has increased by 37% YoY and by 2.1% from the previous quarter

The P/S is 33% above the 5-year quarterly average of 4.5 and 11% above the last 4 quarters average of 5.4

How efficient is Thermo Fisher Scientific business performance

TMO's return on invested capital has surged by 63% year-on-year but it is down by 3.7% since the previous quarter

TMO's ROA has soared by 55% YoY but it is down by 3.9% from the previous quarter

The ROE has grown by 45% YoY but it has contracted by 5% from the previous quarter

TMO's ROS is up by 28% year-on-year but it is down by 2.9% since the previous quarter

What is TMO's dividend history

DPS

$1.04

Dividend yield

0.18%

Payout ratio

4.8%

Recent dividends

How did Thermo Fisher Scientific financials performed over time

The total assets is 111% greater than the total liabilities

Thermo Fisher Scientific's quick ratio has increased by 26% from the previous quarter and by 11% YoY

The current ratio has increased by 15% since the previous quarter and by 9% year-on-year

The debt is 44% lower than the equity

The company's equity rose by 22% YoY and by 5% QoQ

The debt has increased by 16% QoQ and by 2.9% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.